Category: Edwards LifesciencesSyndicate content

TCT 2014: TAVI takes center stage

September 15, 2014 by Brad Perriello

Transcatheter aortic valve implants take center stage at the annual Transcatheter Cardiovascular Therapeutics conference with the latest data dumps from rivals Medtronic and Edwards Lifesciences.

TCT 2014: TAVI takes center stage

TAVI: Symetis battles the big dogs

September 15, 2014 by Arezu Sarvestani

Symetis has been battling Medtronic and Edwards Lifesciences for years in the European transcatheter aortic valve implantation market, and the company's aiming to squeeze out Boston Scientific, St. Jude Medical and other major players in the U.S.

Symetics battles the big dogs in TAVI

Switzerland-based medical implant maker Symetis is looking to make some major moves in the global transcatheter aortic valve implantation market, and the company's not afraid to take on some of the medtech industry's biggest players.

Novation gets into heart valves with Edwards Lifesciences

September 3, 2014 by Brad Perriello

Group purchasing organization Novation inks a sole-source deal with Edwards Lifesciences for replacement heart valves.

Novation gets into heart valves with Edwards Lifesciences

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA grants Philips clearance for 3D TAVI software | Regulatory news for the week of August 25, 2014

August 26, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Philips wins FDA nod for 3D TAVI planning software; Direct Flow wins CE Marks for TAVI device; FDA OKs return of Covidien's Pipeline embolism device; FDA delays UDI rule for contacts, intraocular lenses; Cardiovascular Systems recalls some Diamondback devices on embolism risk

Philips wins FDA nod for 3D TAVI planning software

August 21, 2014 by Brad Perriello

Philips wins FDA nod for 3D TAVI planning software

August 21, 2014 by Brad Perriello

Philips Healthcare wins 510(k) clearance from the FDA for its 3D planning software for transcatheter aortic valve implants.

Philips wins FDA nod for 3D TAVI planning software

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic claims a 40% share of U.S. TAVI market with CoreValve

August 20, 2014 by Brad Perriello

Medtronic CEO Omar Ishrak says the medical device company's CoreValve replacement heart valve has captured more than 40% of the U.S. transcatheter aortic valve implant market in just 2 quarters.

Medtronic claims a 40% share of U.S. TAVI market with CoreValve

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

BSX wins personal injury lawsuit over its Pinnacle pelvic mesh product | Medtech legal news for the week of August 4, 2014

August 4, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific prevails in 1st pelvic mesh trial; Bard settles more than 500 pelvic mesh complaints; Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year; Ex-sales rep's counter-claims stand in poaching spat with Stryker; ResMed kicks Apex sleep masks out of Germany

Boston Scientific prevails in 1st pelvic mesh trial

July 30, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp